-
Alzheimer’s Disease: Charting the Course from Plaques to Promise
Muhammad Farhan Khalid
May 28, 2025
New Tools，New Hope，New Frontier
-
BMS exercises option for US licence of Prothena’s Alzheimer’s antibody
pharmaceutical-technology
June 28, 2021
Bristol Myers Squibb (BMS) has exercised an option under a neuroscience research and development partnership, to obtain an exclusive US licence to Prothena’s anti-tau antibody, PRX005.
-
Tel Aviv University develops novel lipid nanoparticle-based delivery system to destroy cancer cells
expresspharma
January 05, 2021
The system, called CRISPR-LNPs, carries a genetic messenger (messenger RNA), which encodes for the CRISPR enzyme Cas9 that acts as molecular scissors that cut the cells’ DNA.
-
TAU and Neovii team up to develop Covid-19 vaccine
pharmaceutical-technology
May 14, 2020
Israel-based Tel Aviv University (TAU)’s technology transfer company Ramot has entered a research and licence agreement with Swiss-based biopharmaceutical company Neovii to develop a vaccine against Covid-19.
-
Too Much Napping May Signal Alzheimer's
drugs
August 13, 2019
If you often find yourself dosing off during the day, new research suggests it might be an early warning sign that you have Alzheimer's disease.
-
PET tracer able to image tau in Alzheimer’s disease patients
europeanpharmaceuticalreview
December 07, 2018
Research into detecting tau proteins in the brains of Alzheimer’s patients has shown that a specific tracer could detect and measure the protein levels…
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight January 2025
